UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036036
Receipt number R000040876
Scientific Title Effects of supplementary protein powder on American football players' body composition
Date of disclosure of the study information 2019/02/28
Last modified on 2021/01/05 09:55:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of supplementary protein powder on American football players' body composition

Acronym

Protein powder study

Scientific Title

Effects of supplementary protein powder on American football players' body composition

Scientific Title:Acronym

Protein powder study

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of consuming EMIQ with supplementary protein powder on American football players' changes in body composition.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of Body composition parameters using DXA (0,4 month)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Test group
Duration: 4 months, 6 times a week
Test material: supplementary protein powder with EMIQ


Interventions/Control_2

Placebo group:
Duration: 4 months, 6 times a week
Test material: supplementary protein powder

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male

Key inclusion criteria

Male Japanese students who played American football(BMI >=18.5 and <30)

Key exclusion criteria

Subject with food allergy.
Subject who consumes other supplementary protein powder, drug or supplement during the study.
Subject who changes lifestyle, including dietary and exercise habit, during the study.
Subject who eats unbalanced diet (consuming much polyphenol-rich food, such as citrus fruit, buckwheat, and fermented soybeans), and consumes excessive alcohol.
Subject who refrained from practice for long periods (e.g., because of injury).

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naomi Omi

Organization

University of Tsukuba

Division name

Faculty of Health and Sport Sciences

Zip code


Address

1-1-1, Tennou dai, Tsukuba city

TEL

029-853-6319

Email

ominaomi@taiiku.tsukuba.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naomi Omi

Organization

University of Tsukuba

Division name

Faculty of Health and Sport Sciences

Zip code


Address

1-1-1, Tennou dai, Tsukuba city

TEL

029-853-6319

Homepage URL


Email

ominaomi@taiiku.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Morinaga & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 07 Month 30 Day

Date of IRB

2014 Year 07 Month 30 Day

Anticipated trial start date

2014 Year 07 Month 31 Day

Last follow-up date

2014 Year 12 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 28 Day

Last modified on

2021 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040876


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name